HDAC-IN-4
HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC50s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activity[1].
Product Specifications
CAS Number
1252003-13-6
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-4-1.html
Purity
98.00
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NO)C1=CC=C(CN2C(CN(C)CC3)=C3C4=C2C=CC=C4)C=C1
Molecular Formula
C20H21N3O2
Molecular Weight
335.40
References & Citations
[1]Géraldy M, et al. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated. J Med Chem. 2019 May 9;62 (9) :4426-4443.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683276-500 1x 500 µL
Cathepsin D (Tumor Marker) (CTSD/3276), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401019-100 1x 100 µL
CD50 (ICAM-3) (ICAM3/1019), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
